Of all the physiological parameters affecting human health, few have generated such an overwhelming consensus of adverse effects as obesity (typically defined as having a body mass index [BMI] ≥30). The incidence of obesity has been steadily rising in developed countries, reaching pandemic proportions, with a prevalence of more than 39% in the United States and continuing to increase.1 It is therefore critical to understand the potential effects of obesity on disease incidence and progression and on treatment outcomes.
Murphy WJ, Longo DL. The Surprisingly Positive Association Between Obesity and Cancer Immunotherapy Efficacy. JAMA. 2019;321(13):1247–1248. doi:10.1001/jama.2019.0463
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.